| Target Price | $234.60 |
| Price | $260.51 |
| Deviation | 9.95% |
| Number of Estimates | 62 |
| 62 Analysts have issued a price target Alphabet 2026 . The average Alphabet target price is $234.60. This is 9.95% lower than the current stock price. The highest price target is $315.00 20.92% , the lowest is $174.73 32.93% . | |
| A rating was issued by 73 analysts: 60 Analysts recommend Alphabet to buy, 13 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Alphabet stock has an average upside potential 2026 of 9.95% . Most analysts recommend the Alphabet stock at Purchase. |
69 Analysts have issued a sales forecast Alphabet 2025 . The average Alphabet sales estimate is $407b . This is 9.52% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $421b 13.27% , the lowest is $381b 2.66% .
This results in the following potential growth metrics:
| 2024 | $350b | 13.87% |
|---|---|---|
| 2025 | $407b | 16.21% |
| 2026 | $454b | 11.57% |
| 2027 | $501b | 10.48% |
| 2028 | $557b | 11.06% |
| 2029 | $616b | 10.63% |
| 2030 | $688b | 11.67% |
| 2031 | $748b | 8.73% |
| 2032 | $742b | 0.87% |
54 Analysts have issued an Alphabet EBITDA forecast 2025. The average Alphabet EBITDA estimate is $182b . This is 44.71% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $191b 52.00% , the lowest is $169b 34.94% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $129b | 28.78% |
|---|---|---|
| 2025 | $182b | 40.88% |
| 2026 | $210b | 15.80% |
| 2027 | $241b | 14.66% |
| 2028 | $275b | 14.05% |
| 2029 | $317b | 15.14% |
| 2030 | $368b | 16.20% |
| 2031 | $411b | 11.49% |
| 2024 | 36.86% | 13.10% |
|---|---|---|
| 2025 | 44.68% | 21.23% |
| 2026 | 46.37% | 3.78% |
| 2027 | 48.13% | 3.80% |
| 2028 | 49.42% | 2.68% |
| 2029 | 51.44% | 4.09% |
| 2030 | 53.52% | 4.04% |
| 2031 | 54.88% | 2.54% |
70 Alphabet Analysts have issued a net profit forecast 2025. The average Alphabet net profit estimate is $124b . This is 7.27% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $134b 16.02% , the lowest is $109b 5.88% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $100b | 35.67% |
|---|---|---|
| 2025 | $124b | 23.83% |
| 2026 | $132b | 6.73% |
| 2027 | $150b | 13.30% |
| 2028 | $174b | 16.36% |
| 2029 | $221b | 26.75% |
| 2030 | $272b | 23.17% |
| 2031 | $314b | 15.24% |
| 2024 | 28.60% | 19.15% |
|---|---|---|
| 2025 | 30.48% | 6.56% |
| 2026 | 29.16% | 4.33% |
| 2027 | 29.90% | 2.54% |
| 2028 | 31.33% | 4.78% |
| 2029 | 35.90% | 14.59% |
| 2030 | 39.59% | 10.28% |
| 2031 | 41.96% | 5.99% |
70 Analysts have issued a Alphabet forecast for earnings per share. The average Alphabet EPS is $10.24 . This is 8.13% higher than earnings per share in the financial year 2024. The highest EPS forecast is $11.08 17.00% , the lowest is $8.99 5.07% .
This results in the following potential growth metrics and future valuations:
| 2024 | $7.52 | 28.77% |
|---|---|---|
| 2025 | $10.24 | 36.17% |
| 2026 | $10.93 | 6.74% |
| 2027 | $12.39 | 13.36% |
| 2028 | $14.41 | 16.30% |
| 2029 | $18.27 | 26.79% |
| 2030 | $22.50 | 23.15% |
| 2031 | $25.93 | 15.24% |
| Current | 26.79 | 23.21% |
|---|---|---|
| 2025 | 24.77 | 7.55% |
| 2026 | 23.21 | 6.30% |
| 2027 | 20.48 | 11.76% |
| 2028 | 17.60 | 14.06% |
| 2029 | 13.89 | 21.08% |
| 2030 | 11.28 | 18.79% |
| 2031 | 9.78 | 13.30% |
Based on analysts' sales estimates for 2025, the Alphabet stock is valued at an EV/Sales of 7.37 and an P/S ratio of 7.54 .
This results in the following potential growth metrics and future valuations:
| Current | 8.07 | 41.83% |
|---|---|---|
| 2025 | 7.37 | 8.70% |
| 2026 | 6.60 | 10.37% |
| 2027 | 5.98 | 9.49% |
| 2028 | 5.38 | 9.96% |
| 2029 | 4.86 | 9.61% |
| 2030 | 4.36 | 10.45% |
| 2031 | 4.01 | 8.03% |
| 2032 | 4.04 | 0.88% |
| Current | 8.25 | 39.33% |
|---|---|---|
| 2025 | 7.54 | 8.69% |
| 2026 | 6.75 | 10.37% |
| 2027 | 6.11 | 9.49% |
| 2028 | 5.51 | 9.96% |
| 2029 | 4.98 | 9.61% |
| 2030 | 4.46 | 10.45% |
| 2031 | 4.10 | 8.03% |
| 2032 | 4.13 | 0.88% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Oct 20 2025 |
| Guggenheim |
Buy
➜
Buy
|
Unchanged | Oct 17 2025 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 09 2025 |
| HSBC |
➜
Buy
|
Initiated | Oct 07 2025 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 07 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 02 2025 |
| Mizuho |
➜
Outperform
|
Initiated | Sep 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Oct 20 2025 |
|
Unchanged
Guggenheim:
Buy
➜
Buy
|
Oct 17 2025 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Oct 09 2025 |
|
Initiated
HSBC:
➜
Buy
|
Oct 07 2025 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Oct 07 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 02 2025 |
|
Initiated
Mizuho:
➜
Outperform
|
Sep 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


